EU Court Upholds Silanamine Hazard Classification in Evonik Appeal

By Public Technologies
  • The European Court of Justice upheld silanamine’s STOT RE 2 hazard classification, rejecting Evonik’s challenge.
  • The classification covers lung toxicity from repeated inhalation exposure. Evonik had challenged reliance on test results from other surface-modified silicas.
  • The court confirmed that hazard assessments may use data from structurally or physicochemically comparable substances through the read-across method.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Evonik Venture Capital GmbH published the original content used to generate this news brief on November 06, 2026, and is solely responsible for the information contained therein.

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk